Cargando…
Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis
The role of interleukin-13 in mediating ulcerative colitis remains under scrutiny. Compelling evidence from both man and mouse suggests that IL-13 not only contributes to the pathology associated with disease but is also involved in mediating the inflammatory response. These studies have led to the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232290/ https://www.ncbi.nlm.nih.gov/pubmed/30460209 http://dx.doi.org/10.3389/fcimb.2018.00395 |